IL159462A0 - Method and material for treating immune diseases - Google Patents

Method and material for treating immune diseases

Info

Publication number
IL159462A0
IL159462A0 IL15946202A IL15946202A IL159462A0 IL 159462 A0 IL159462 A0 IL 159462A0 IL 15946202 A IL15946202 A IL 15946202A IL 15946202 A IL15946202 A IL 15946202A IL 159462 A0 IL159462 A0 IL 159462A0
Authority
IL
Israel
Prior art keywords
immune diseases
treating immune
treating
diseases
immune
Prior art date
Application number
IL15946202A
Other languages
English (en)
Original Assignee
Glycogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycogenesys Inc filed Critical Glycogenesys Inc
Publication of IL159462A0 publication Critical patent/IL159462A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL15946202A 2001-06-22 2002-06-21 Method and material for treating immune diseases IL159462A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30036001P 2001-06-22 2001-06-22
US10/176,022 US20030004132A1 (en) 2001-06-22 2002-06-20 Method and material for treating immune diseases
PCT/US2002/019886 WO2003000195A2 (en) 2001-06-22 2002-06-21 Method and material for treating immune diseases

Publications (1)

Publication Number Publication Date
IL159462A0 true IL159462A0 (en) 2004-06-01

Family

ID=26871794

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15946202A IL159462A0 (en) 2001-06-22 2002-06-21 Method and material for treating immune diseases

Country Status (8)

Country Link
US (1) US20030004132A1 (enExample)
EP (1) EP1408989A2 (enExample)
JP (1) JP2004536825A (enExample)
CN (1) CN100558368C (enExample)
BR (1) BR0210547A (enExample)
CA (1) CA2451885A1 (enExample)
IL (1) IL159462A0 (enExample)
WO (1) WO2003000195A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1980257A1 (en) 2003-04-07 2008-10-15 Prospect Therapeutics, Inc. Compositions and uses of galectin antagonists
US20040223971A1 (en) * 2003-04-07 2004-11-11 Glycogenesys, Inc. Composition and uses of galectin antagonists
WO2005058352A2 (en) * 2003-12-17 2005-06-30 Entelos, Inc. Treatment of rheumatoid arthritis with galectin-3 antagonists
EP1765874A1 (en) 2004-03-26 2007-03-28 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
CN103718046B (zh) 2011-03-17 2016-10-12 重症监护诊断股份有限公司 预测不良临床结果的风险的方法
CN104245717B (zh) 2011-12-28 2017-10-24 卡莱克汀医疗有限公司 用于治疗人类疾病的新型糖类药物的组合物
WO2013184892A1 (en) * 2012-06-06 2013-12-12 Galectin Therapeutics, Inc. Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
JP6415437B2 (ja) 2012-09-17 2018-10-31 ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 癌の処置における特異的免疫療法を向上する方法
KR102231732B1 (ko) 2012-10-10 2021-03-23 갈렉틴 테라퓨틱스, 인크. 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물
JP2016507503A (ja) 2012-12-20 2016-03-10 ヘンリー フォード ヘルス システム ガレクチン−３を阻害することによる拡張期心不全を治療する方法
US12390486B2 (en) 2012-12-20 2025-08-19 Henry Ford Health System Method for treating diastolic heart failure by inhibiting galectin-3
US9339515B2 (en) 2013-02-20 2016-05-17 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
CA3088736A1 (en) * 2018-01-21 2019-07-25 Rensselaer Polytechnic Institute Method of treating galectin-3 dependent disorders
CA3102155A1 (en) 2018-06-29 2020-01-02 Glykos Biomedical Oy Conjugates
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490991A (en) * 1986-07-03 1996-02-13 Advanced Magnetics, Inc. Directed delivery of radioprotectants using a receptor specific carrier
WO1992000310A1 (en) * 1990-06-27 1992-01-09 Dainippon Ink & Chemicals, Inc. Alkylated oligosaccharide and acetyl derivative thereof
US5498702A (en) * 1993-12-16 1996-03-12 California Natural Products Treated pectinic acid process and product
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
CA2279791C (en) * 1998-08-14 2011-11-08 Marcus B. Gohlke Dietary supplement combining colostrum and lactorferrin in a mucosal delivery format
US6500807B1 (en) * 1999-02-02 2002-12-31 Safescience, Inc. Modified pectin and nucleic acid composition
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies

Also Published As

Publication number Publication date
EP1408989A2 (en) 2004-04-21
WO2003000195A2 (en) 2003-01-03
US20030004132A1 (en) 2003-01-02
CN100558368C (zh) 2009-11-11
JP2004536825A (ja) 2004-12-09
CA2451885A1 (en) 2003-01-03
WO2003000195A3 (en) 2003-03-20
CN1543352A (zh) 2004-11-03
BR0210547A (pt) 2004-05-25

Similar Documents

Publication Publication Date Title
IL157684A0 (en) Apparatus and method for photocosmetic and photodermatological treatment
EP1407114A4 (en) APPARATUS AND METHOD FOR INSTALLING ANCHOR BOLTS
GB0111413D0 (en) Apparatus and method
GB0110288D0 (en) Composition and treatment method
GB0101259D0 (en) Apparatus and method
GB0129976D0 (en) Treatment method
IL160561A0 (en) Method and composition for treating immune complex associated disorders
GB0105688D0 (en) Apparatus and method
GB0110732D0 (en) Apparatus and method
GB0109628D0 (en) Apparatus and method
EP1400212A4 (en) APPARATUS AND METHOD FOR TREATING JOINT DISEASES
EP1435772A4 (en) AQUACULTURE PROCESS AND DEVICE
GB0120147D0 (en) Treatment method
GB0319239D0 (en) Process and apparatus
EP1371744A4 (en) STEEL MATERIAL AND METHOD FOR MANUFACTURING THE SAME
GB0124303D0 (en) Material fabrication method and apparatus
SG102679A1 (en) Surface treatment method and material treated by the method
AU2002364679A1 (en) Method and compositions for treating respiratory pathologies
GB0101084D0 (en) Apparatus and method
GB0111411D0 (en) Apparatus and method
HK1064612A (en) Method and material for treating immune diseases
GB0114342D0 (en) Apparatus and method
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
GB0107458D0 (en) Method and apparatus
AU2003259514A8 (en) Apparatus and method for treating infectious diseases